Use of bluetongue virus proteins as vaccine components
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 10, 1998
Issued Date -
N/A
app pub date -
Aug 18, 1994
filing date -
Jul 7, 1989
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A protective effect against bluetongue infection in susceptible mammals which is obtained by innoculating said mammals with a polypeptide comprising at least an antigenic portion of bluetongue virus structural protein VP2 in antigenic form produced by transforming a host with a recombinant expression vector having a DNA segment coding for said polypeptide.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully